
The BioTechnique facility encompasses 268,000 sq ft and sits on 39 acres, with opportunities for future expansion. The facility is equipped with 9 cleanroom suits and advanced manufacturing capabilities.

Orders and inventory are tracked using ACE, PSC Software's AI-Powered quality management system (QMS) and workflow automation platform.

Completion of major facility and security upgrades were a part of BioTechnique's process for DEA approval.
New license expands BioTechnique’s capabilities in controlled‑substance manufacturing and secure pharmaceutical development.
YORK, PA, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- BioTechnique is pleased to announce the successful issuance of its Drug Enforcement Administration (DEA) manufacturing and handling license, marking a





